DrugPatentWatch

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Generic Name: ritonavir

Summary for Generic Name: ritonavir

Tradenames:1
Patents:17
Applicants:2
NDAs:4
Drug Master File Entries: see list21
Suppliers: see list1
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details

Tentative approvals for RITONAVIR

Applicant Application No. Form Dosage
<disabled><disabled>TABLET;ORAL100MG

Clinical Trials for: ritonavir

Drug-drug Interaction Study Between Lopinavir/Ritonavir and Isavuconazole
Status: Completed Condition: Pharmacokinetics of Isavuconazole; Pharmacokinetics of Lopinavir/Ritonavir; Healthy Volunteers

Pharmacokinetics (PK) Study of Once Daily Darunavir/Ritonavir and Twice and Once Daily Raltegravir in HIV-infected Subjects
Status: Completed Condition: HIV Infections

Bioequivalence Study of Generic GPO Ritonavir Versus NorvirĀ®
Status: Completed Condition: Healthy

Drug Interactions Between Voriconazole and Atazanavir Coadministered as Atazanavir/Ritonavir in Healthy Participants
Status: Completed Condition: Human Immunodeficiency Virus Type 1 (HIV-1); HIV Infections

Genetic Predictors of Variability in the Drug-drug Interaction Between Darunavir/Ritonavir and Pravastatin
Status: Completed Condition: HIV Infections; Hyperlipidemia

Pharmacokinetics of Lopinavir/Ritonavir at Three Different Doses.
Status: Completed Condition: Acquired Immunodeficiency Syndrome

Courtesy of ClinicalTrials.org
See more clinical trials for this drug

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Abbott
NORVIR
ritonavir
CAPSULE;ORAL020680Mar 1, 1996DISCNNo5,541,206*PED<disabled>Y
Abbott
NORVIR
ritonavir
CAPSULE;ORAL020680Mar 1, 1996DISCNNo5,635,523*PED<disabled>Y
Abbott
NORVIR
ritonavir
CAPSULE;ORAL020680Mar 1, 1996DISCNNo5,648,497*PED<disabled>Y
Abbott
NORVIR
ritonavir
CAPSULE;ORAL020680Mar 1, 1996DISCNNo5,948,436*PED<disabled>Y
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc